SCHOTT Glass Strenghtens India Facility As Asian Hub
Express Pharma|December 16-31, 2019
With investments of close to €47 million in India over two years, global pharmaceutical glass manufacturer SCHOTT AG clearly sees the country as a vital cog in its global strategy. Georg Sparschuh, MD, SCHOTT Glass India and Dr Patrick Markschläger, Executive VP, SCHOTT AG, Business Unit Tubing reveal the company's strategy to build India into an Asian hub for SCHOTT pharma tubing, their endeavours to be as sustainable as posssible and how investing in the futures of the communities in which their manufacturing plants are based is simply good business practice
Viveka Roychowdhury
SCHOTT Glass Strenghtens India Facility As Asian Hub

Twenty-one years after it bought over a company producing pharmaceutical tubing in Jambusar district in Gujarat state, SCHOTT AG has earmarked the plant as a production hub not just for the country, but for SCHOTT pharma tubing in Asia.

The plant is an ideal example of Prime Minister Modi's campaign to “Make in India, for the world.” According to Georg Sparschuh, MD, SCHOTT Glass India, the Jambusar plant had reached up to 40 per cent export rate, in addition to the rapidly growing domestic demand. While domestic demands have been their main focus, the increased capacity with two new tanks is expected to cater to the exports, which may even cross 40 per cent.

Solely owned by the Carl Zeiss Foundation, the parent company SCHOTT AG is present across many sectors besides pharma and life sciences, including home appliances, electronics, optics, automotive and aviation industries. The company has production sites and sales offices in 34 countries.

In fiscal year 2017/2018 (October 1, 2017, to September 30, 2018), Mainz, Germany headquartered company clocked global sales of Euro 2.08 billion in 34 countries, with Europe's share the highest (46 per cent, Euro 963 million; 9,450 employees).

The Asia and South Pacific region made up 25 per cent of sales (Euro 517 million; 2,800 employees) with North America in the third place, with 23 per cent sales (Euro 475 million; 2,050 employees). The annual report does not provide a break out of sales per segment, but Dr. Patrick Markschläger, Executive VP, SCHOTT AG, Business Unit Tubing indicated that pharmaceuticals - Pharmaceutical Tubing and Packaging - is the biggest business for SCHOTT Glass.

この記事は Express Pharma の December 16-31, 2019 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

この記事は Express Pharma の December 16-31, 2019 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

EXPRESS PHARMAのその他の記事すべて表示
MAKING SUSTAINABILITY SUSTAINABLE
Express Pharma

MAKING SUSTAINABILITY SUSTAINABLE

Driven by stringent regulations, rising investor expectations, consumer demand, and operational considerations, MSME pharma companies need to carefully balance their sustainability goals with financial viability

time-read
10+ 分  |
September 2024
New energy recovery system for tablet coaters
Express Pharma

New energy recovery system for tablet coaters

Upto 50 per cent less steam energy consumption

time-read
5 分  |
September 2024
The future of pharma logistics: Trends, challenges, and opportunities
Express Pharma

The future of pharma logistics: Trends, challenges, and opportunities

Nikhil Agarwal, President, CJ Darcl Logistics explains that the future of pharma logistics is a thrilling frontier shaped by technological advancements, regulatory challenges, and the imperative of sustainability. As the industry transforms, logistics providers must embrace innovative solutions and adapt to shifting demands

time-read
3 分  |
September 2024
Achieving Aatmanirbharta In APIs Are We On The Right Track?
Express Pharma

Achieving Aatmanirbharta In APIs Are We On The Right Track?

As India gears up to celebrate its 75th Independence Day, self reliance in APIs remains a key goal for the pharma sector. AatmaNirbharta will be crucial for the sector as it continues to protect the country from the existing and emerging health threats

time-read
9 分  |
August 2021
Yokogawa launches OpreX Data Model Broker
Express Pharma

Yokogawa launches OpreX Data Model Broker

A plant data transformation platform, OpreX automatically verifies discrepancies and inconsistencies in data to improve efficiency in plant construction and operation

time-read
2 分  |
August 2021
Understanding the nuances of generics injectables
Express Pharma

Understanding the nuances of generics injectables

At a webinar, explaining the West Pharma's AccelTRA Components Program, industry experts explained why the use of glass vials and stoppers as primary container closure systems (CCS) has become crucial

time-read
6 分  |
August 2021
Trending in nutraceuticals: Science meets sustainability
Express Pharma

Trending in nutraceuticals: Science meets sustainability

Zeljko Pockaj, Vice President, Global Pharmaceutical Industry, mentions the key trends that are believed to drive innovations and formulations for nutraceuticals’ development around the globe

time-read
3 分  |
August 2021
The growth of e-pharmacies in India
Express Pharma

The growth of e-pharmacies in India

Rahul Nath Choudhury, Research fellow, ICWA, explains what motivates people in the pharma industry to invest into e-pharmacies, along with various other growth factors associated with these

time-read
4 分  |
August 2021
Xylitol and Maltitol: Low-calorie sugar alternatives
Express Pharma

Xylitol and Maltitol: Low-calorie sugar alternatives

Polyols like Xylitol and Maltitol offer important health benefits. Unlike general sugar-free sweeteners, these do not have any bitter-after taste

time-read
4 分  |
August 2021
Single-use TC gaskets and their importance
Express Pharma

Single-use TC gaskets and their importance

Depending on the application, gaskets are manufactured by different types of Material of Construction (MOC) such as Silicone, EPDM, Viton (FKM), Nitrile, Neoprene, PTFE, etc.

time-read
2 分  |
August 2021